Market Cap 0.00
Revenue (ttm) 80.38M
Net Income (ttm) -10.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13.17%
Debt to Equity Ratio 0.00
Volume 59,500
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 0.00
Stochastic %K 0%
Beta 0.43
Analysts Strong Buy
Price Target N/A

Company Profile

Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headq...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 514-928-7368
Website: wuhn.org
Address:
6500 Transcanada hwy, Suite 400, Pointe-Claire, Canada
Anniesdad
Anniesdad May. 29 at 3:32 PM
0 · Reply
Latest News on WUHN
No data available.
Anniesdad
Anniesdad May. 29 at 3:32 PM
0 · Reply